<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-I3R25IXL/575842cd-66b6-43b1-8fd8-cda7be6867fd/HTML"><dcterms:extent>44 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-I3R25IXL/66b9080f-b8c8-4579-8704-941ab1448eb3/PDF"><dcterms:extent>101 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-I3R25IXL/52225022-7cb4-4dcd-9e14-0c7cfa9db4c1/TEXT"><dcterms:extent>24 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-I3R25IXL"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>2004</dcterms:issued><dc:creator>Strojan, Primož</dc:creator><dc:format xml:lang="sl">številka:2</dc:format><dc:format xml:lang="sl">letnik:38</dc:format><dc:format xml:lang="sl">8 strani</dc:format><dc:format xml:lang="sl">str. 93-100</dc:format><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>COBISSID:18166233</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-I3R25IXL</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Association of Radiology and Oncology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="en">Carcinoma, Squamous Cell</dc:subject><dc:subject xml:lang="en">Cathepsins</dc:subject><dc:subject xml:lang="sl">Cistatini</dc:subject><dc:subject xml:lang="en">Cystatins</dc:subject><dc:subject xml:lang="en">diagnostika</dc:subject><dc:subject xml:lang="sl">glava</dc:subject><dc:subject xml:lang="sl">Glava in vrat, novotvorbe</dc:subject><dc:subject xml:lang="en">Head And Neck Neoplasms</dc:subject><dc:subject xml:lang="sl">karcinom</dc:subject><dc:subject xml:lang="sl">Karcinom ploščatocelični</dc:subject><dc:subject xml:lang="sl">Katepsini</dc:subject><dc:subject xml:lang="sl">Limfatična metastaza</dc:subject><dc:subject xml:lang="en">Lymphatic Metastasis</dc:subject><dc:subject xml:lang="sl">onkologija</dc:subject><dc:subject xml:lang="en">Prognosis</dc:subject><dc:subject xml:lang="sl">Prognoza</dc:subject><dc:subject xml:lang="sl">rak (medicina)</dc:subject><dc:subject xml:lang="sl">tumorski označevalci</dc:subject><dc:subject xml:lang="sl">vrat</dc:subject><dc:subject xml:lang="en">Vrata</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Cathepsins and their inhibitors as tumor markers in head and neck cancer|</dc:title><dc:description xml:lang="sl">The invasion and metastasizing of tumor cells is closely connected with the disintegration of basement membranes and extracellular matrix. The carriers ofthese processes are different proteolytic enzymes, among them cysteine and aspartic cathepsins B, H, L and D as well, a group of ubiquitous lysosomal proteases, and endogenous inhibitors of the former, cystatins. The aim of the present review was to collect the current knowledge on the predictive and prognostic value of cathepsins and their inhibitors in squamous cell carcinomaof the head and neck. In this particular tumor type, the UICC/AJCC TNM-classification system and histopathological characteristics of the tumors were found inadequate to reliably predict either the response to therapy or patients' survival. Moreover, to date, no factor within the wide spectrum of biochemical and histological factors has yet been idenrified as reliably predicting the natural course of the disease or its response to therapy. To construct a prognostically meaningful tumor profile, new markers are intensively investigated</dc:description><dc:description xml:lang="sl">Invazija in zasevanje tumorskih celic sta tesno povezana z razgradnjo bazalnihmembran in zunajceličnega matriksa. Nosilci teh procesov so različni proteolitični encimi, med njimi tudi skupina ubikvitarnih lizosomskih encimov,tj cisteinske proteaze katepsini B, H in L, aspartatna proteaza katepsin D in endogeni inhibitorji prvih, cistatini. Namen tega pregleda je bil zbrati dosedanje vedenje o napovedni in prognostični vrednosti katepsinov in njihovih inhibitorjev pri ploščatoceličnem karcinomu glave in vratu. Pri tej vrsti raka so se UICC/AJCC TNM-klasifikacijski sistem in histopatološke značilnosti tumorjev izkazali kot nezanesljivi kazalci za napoved bodisi odgovora na zdravljenje bodisi preživetja bolnikov. Poleg tega do sedaj še noben dejavnik iz širokega spektra biokemičnih in histoloških dejavnikov ni bil spoznan kot zanesljiv napovedovalec naravnega poteka bolezni ali odgovora na zdravljenje. Prav z namenom izdelati zanesljiv prognostični profil tumorja potekajo intenzivne raziskave številnih novih označevalcev</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-I3R25IXL"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-I3R25IXL" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-I3R25IXL/66b9080f-b8c8-4579-8704-941ab1448eb3/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo radiologije in onkologije</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-I3R25IXL/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-I3R25IXL" /></ore:Aggregation></rdf:RDF>